NEWLY REDESIGNED JDDONLINE PROVIDES FASTER, MORE USER-FRIENDLY
ACCESS TO THE JOURNAL OF DRUGS IN DERMATOLOGY
New York (June 18, 2019)– The Journal of Drugs in Dermatology (JDD) has a newly revamped website, JDDonline.com, which offers a fully-responsive design for more user-friendly browsing. With updated navigation, seamless transition from desktop to mobile viewing and new search features, subscribers are able to access JDD content, renew their subscriptions and view multimedia faster and easier than ever before.
“Our goal is to get the latest dermatologic research into the hands of clinicians as quickly and easily as possible so that the latest advancements can be further researched and implemented,” said Shelley Tanner, CEO and president of SanovaWorks, parent company of the JDD.
The redesigned site makes it easier to navigate the journal’s award-winning content, including multimedia, such as the JDD Podcastand Translational Lecture Series. In addition, subscribers can view PDFs of articles and archived issues.
The journal has also launched a new manuscript submission and peer-review site. The updated, streamlined submission process facilitates compliance with publishing requirements and allows fast, easy upload of manuscript files, figures and materials. The manuscript submission site can be accessed from JDDonline.comby clicking on the Authors tab at the top of the page or by visiting the site directly at jdd.msubmit.net.
“The manuscript submission process is easy to follow, which ensures completeness, quality control and timely submission,” Tanner said. “From the submission process to the final product, the Journal of Drugs in Dermatologystrives to be the leader in dermatologic publishing.”
The Journal of Drugs in Dermatology (JDD), a full-color, peer-reviewed publication indexed with MEDLINE®/PubMed®, was founded by dermatologist Perry Robins, MD. Now in its 18th year, it offers one of the fastest routes to disseminate dermatologic information, and is considered the fastest growing publication in dermatology, presenting original articles, award-winning case reports and timely features pertaining to new methods, techniques and drug therapy that provide readers with peer-reviewed content of the utmost quality. The JDD is overseen by an International Editorial Board of more than 160 renowned experts and reaches more than 30,000 dermatology healthcare practitioners worldwide.